Benign hereditary chorea: Difference between revisions
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{ | {{Short description|A rare genetic movement disorder}} | ||
| | {{Use dmy dates|date=October 2023}} | ||
}} | |||
BHC is | '''Benign hereditary chorea''' (BHC) is a rare [[genetic disorder]] characterized by early-onset [[chorea]], a type of [[movement disorder]] that involves involuntary, irregular, and unpredictable muscle movements. BHC is considered "benign" because it does not typically progress to more severe neurological conditions, unlike other forms of chorea. | ||
==Etiology== | |||
Benign hereditary chorea is primarily caused by mutations in the [[NKX2-1 gene]], also known as the TITF1 gene, located on chromosome 14. This gene is crucial for the development of the [[brain]], [[thyroid]], and [[lungs]]. Mutations in NKX2-1 can lead to a triad of symptoms affecting these organs, although in BHC, the primary manifestation is neurological. | |||
== | ==Clinical Features== | ||
The hallmark of BHC is the presence of chorea, which typically presents in [[childhood]]. The movements are often described as "dance-like" and can affect various parts of the body, including the [[face]], [[trunk]], and [[limbs]]. | |||
===Neurological Symptoms=== | |||
- '''Chorea''': Involuntary, rapid, and irregular movements. | |||
- '''Hypotonia''': Decreased muscle tone, which may be present in some individuals. | |||
- '''Mild developmental delay''': Some children may experience delays in reaching motor milestones. | |||
===Non-neurological Symptoms=== | |||
While BHC primarily affects movement, some individuals may also experience: | |||
- '''Thyroid dysfunction''': Such as [[hypothyroidism]] or [[hyperthyroidism]]. | |||
- '''Respiratory issues''': Due to the involvement of the lungs, although this is less common. | |||
==Diagnosis== | |||
Diagnosis of benign hereditary chorea is based on clinical evaluation, family history, and genetic testing. The presence of chorea in a child with a family history of similar symptoms may prompt genetic testing for mutations in the NKX2-1 gene. | |||
==Management== | |||
There is no cure for BHC, but management focuses on alleviating symptoms and improving quality of life. Treatment options may include: | |||
- '''Medications''': Such as [[dopamine antagonists]] or [[benzodiazepines]] to help control chorea. | |||
- '''Physical therapy''': To improve motor skills and muscle strength. | |||
- '''Regular monitoring''': For thyroid function and respiratory health. | |||
== | ==Prognosis== | ||
The prognosis for individuals with benign hereditary chorea is generally favorable. While the chorea can be persistent, it does not typically worsen over time, and many individuals lead normal lives. However, associated conditions such as thyroid dysfunction may require ongoing management. | |||
==Related pages== | |||
* [[Chorea]] | |||
* [[Genetic disorder]] | |||
* [[Movement disorder]] | |||
* [[NKX2-1 gene]] | |||
[[Category:Genetic disorders]] | |||
[[Category:Movement disorders]] | |||
[[Category:Neurology]] | |||
Revision as of 19:24, 22 March 2025
A rare genetic movement disorder
Benign hereditary chorea (BHC) is a rare genetic disorder characterized by early-onset chorea, a type of movement disorder that involves involuntary, irregular, and unpredictable muscle movements. BHC is considered "benign" because it does not typically progress to more severe neurological conditions, unlike other forms of chorea.
Etiology
Benign hereditary chorea is primarily caused by mutations in the NKX2-1 gene, also known as the TITF1 gene, located on chromosome 14. This gene is crucial for the development of the brain, thyroid, and lungs. Mutations in NKX2-1 can lead to a triad of symptoms affecting these organs, although in BHC, the primary manifestation is neurological.
Clinical Features
The hallmark of BHC is the presence of chorea, which typically presents in childhood. The movements are often described as "dance-like" and can affect various parts of the body, including the face, trunk, and limbs.
Neurological Symptoms
- Chorea: Involuntary, rapid, and irregular movements. - Hypotonia: Decreased muscle tone, which may be present in some individuals. - Mild developmental delay: Some children may experience delays in reaching motor milestones.
Non-neurological Symptoms
While BHC primarily affects movement, some individuals may also experience: - Thyroid dysfunction: Such as hypothyroidism or hyperthyroidism. - Respiratory issues: Due to the involvement of the lungs, although this is less common.
Diagnosis
Diagnosis of benign hereditary chorea is based on clinical evaluation, family history, and genetic testing. The presence of chorea in a child with a family history of similar symptoms may prompt genetic testing for mutations in the NKX2-1 gene.
Management
There is no cure for BHC, but management focuses on alleviating symptoms and improving quality of life. Treatment options may include: - Medications: Such as dopamine antagonists or benzodiazepines to help control chorea. - Physical therapy: To improve motor skills and muscle strength. - Regular monitoring: For thyroid function and respiratory health.
Prognosis
The prognosis for individuals with benign hereditary chorea is generally favorable. While the chorea can be persistent, it does not typically worsen over time, and many individuals lead normal lives. However, associated conditions such as thyroid dysfunction may require ongoing management.
